Go back to the Europarl portal

Choisissez la langue de votre document :

  • bg - български
  • es - español
  • cs - čeština
  • da - dansk
  • de - Deutsch
  • et - eesti keel
  • el - ελληνικά
  • en - English (Selected)
  • fr - français
  • ga - Gaeilge
  • hr - hrvatski
  • it - italiano
  • lv - latviešu valoda
  • lt - lietuvių kalba
  • hu - magyar
  • mt - Malti
  • nl - Nederlands
  • pl - polski
  • pt - português
  • ro - română
  • sk - slovenčina
  • sl - slovenščina
  • fi - suomi
  • sv - svenska
Parliamentary questions
PDF 6kWORD 19k
7 December 2018
P-005158/2018(ASW)
Answer given by President Juncker on behalf of the European Commission
Question reference: P-005158/2018

Paragraph 15 of the Guidelines for Brexit negotiations of the European Council (Article 50) of 29 April 2017(1) states that ‘the future location of the seats of EU agencies and facilities located in the United Kingdom is a matter for the 27 Member States to settle rapidly’. On the basis of a procedure endorsed by the Heads of State or Government of all 27 Member States for the relocation of the London-based EU agencies, after three rounds of voting, on 20 November 2017, the 27 Member States selected Amsterdam as the agency's new seat. On 17 October 2018, the European Parliament and the Council agreed on a compromise text for a regulation, which determines that the location of the seat of the European Medicines Agency shall be in Amsterdam.

As regards costs for the European Union budget associated with the need of the Agency to occupy temporary premises before moving into its permanent premises, the Commission informs the Honourable Member that as agreed with the Agency, such costs are to be borne by the Netherlands. The Commission has transmitted the Agency the request by the Honourable Member on costs already incurred by the Agency in its move from London to Amsterdam. The reply will be transmitted by the Commission as soon as possible. Finally, the Commission cannot provide estimates on costs associated with the possible loss of the ongoing court case to Canary Wharf.

(1)https://www.consilium.europa.eu/media/21763/29-euco-art50-guidelinesen.pdf

Last updated: 7 December 2018Legal notice